Fy^xis associated with two missense point mutations in its gene and can be detected by PCR–SSP

[1]Hadley TJ, Peiper SC. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 1997;89:3077–91.10.1182/blood.V89.9.3077Search in Google Scholar

[2]Horuk R, Martin AW, Wang Z, et al. Expression of chemokine receptors by subsets of neurons in the central nervous system.Immunol 1997;158:2882–90.10.4049/jimmunol.158.6.2882Search in Google Scholar

[3]Le Van Kim C, Tournamille C, Kroviarski Y, Cartron JP, Colin Y.The 1.35-kb and 7.5-kb Duffy mRNA isoforms are differently regulated in various regions of brain, differ by the length of their 5’ untranslated sequence, but encode the same polypeptide. Blood 1997;90:2851-3.10.1182/blood.V90.7.2851Search in Google Scholar

[4]Horuk R, Chitnis CE, Darbonne WC, et al.A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993;261: 1182–4.10.1126/science.7689250Search in Google Scholar

[5]Chaudhuri A, Polyakova J, Zbrzezna V, Williams K, Gulati S, Pogo AO. Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite. Proc Natl Acad Sci USA 1993;90:10793–7.10.1073/pnas.90.22.10793Search in Google Scholar

[6]Wasniowska K, Hadley TJ. The Duffy blood group antigen: an update.Transfus Med Rev 1994;8:281–8.10.1016/S0887-7963(94)70119-XSearch in Google Scholar

[7]Tournamille C, Le Van Kim C, Gane P, et el. Close association of the first and fourth extracellular domains of the Duffy antigen/receptor for chemokines by a disulfide bond is required for ligand binding. J Biol Chem 1997;272:16274–80.10.1074/jbc.272.26.16274Search in Google Scholar

[8]Neote K, Mak JY, Kolakowski LF Jr, Schall TJ. Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood 1994;84:44–52.10.1182/blood.V84.1.44.44Search in Google Scholar

[9]Chaudhuri A, Zbrzezna V, Polyakova J, Pogo AO, Hesselgesser J, Horuk R. Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor. J Biol Chem 1994;269:7835–8.10.1016/S0021-9258(17)37123-5Search in Google Scholar

[10]Peiper SC, Wang ZX, Neote K, et al. The Duffy anti- gen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995; 181:1311–7.10.1084/jem.181.4.131121919617699323Search in Google Scholar

[11]Darbonne WC, Rice GC, Mohler MA, et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991;88:1362–9.10.1172/JCI1154422956071918386Search in Google Scholar

[12]Chitnis CE, Chaudhuri A, Horuk R, Pogo AO, Miller LH. The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. J Exp Med 1996;184:1531–6.10.1084/jem.184.4.153121928298879225Search in Google Scholar

[13]Cutbush M, Mollinson PL, Parkin DM.A new human blood group. Nature 1950; 165:188–190.10.1038/165188b0Search in Google Scholar

[14]Ikin RE, Mourant AC, Pellenkofer HJ, Blumenthal G. Discovery of the expected haemagglutinin, anti-Fy^b. Nature 1951;168:1077.10.1038/1681077b014910641Search in Google Scholar

[15]Sanger R, Race RR, Jack J.The Duffy blood groups of the New York Negroes: the phenotype Fy(a–b–). Br J Haematol 1955;1:370–4.10.1111/j.1365-2141.1955.tb05523.x13269673Search in Google Scholar

[16]Chown B, Lewis M, Kaita H.The Duffy blood group system in Caucasians: evidence for a new allele.Am J Hum Genet 1965;10:224.Search in Google Scholar

[17]Mathew S, Chaudhuri A, Murty VV, Pogo AO. Confirmation of Duffy blood group antigen locus (FY) at 1q22’q23 by fluorescence in situ hybridization. Cytogenet Cell Genet 1994;67:68.10.1159/0001338018187556Search in Google Scholar

[18]Iwamoto S, Omi T, Kajii E, Ikemoto S. Genomic organization of the glycoprotein D gene: Duffy blood group Fy^a/Fy^b alloantigen system is associated with a polymorphism at the 44-amino acid residue. Blood 1995;85:622–6.10.1182/blood.V85.3.622.bloodjournal853622Search in Google Scholar

[19]Mallinson G, Soo KS, Schall TJ, Pisacka M, Anstee DJ. Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fy^a/Fy^b antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a–b–) phenotype. Br J Haematol 1995;90:823–9.10.1111/j.1365-2141.1995.tb05202.x7669660Search in Google Scholar

[20]Tournamille C, Le Van Kim C, Gane P, Cartron JP, Colin Y. Molecular basis and PCR–DNA typing of the Fy^a/Fy^b blood group polymorphism. Hum Genet 1995;95:407–10.10.1007/BF002089657705836Search in Google Scholar

[21]Iwamoto S, Li J, Omi T, Ikemoto S, Kajii E. Identification of a novel exon and spliced form of Duffy mRNA that is the predominant transcript in both erythroid and postcapillary venule endothelium. Blood 1996;87:378–85.10.1182/blood.V87.1.378.378Search in Google Scholar

[22]Chaudhuri A, Polyakova J, Zbrzezna V, Pogo AO. The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in nonerythroid tissues in Duffy-negative individuals. Blood 1995;85:615–21.10.1182/blood.V85.3.615.bloodjournal853615Search in Google Scholar

[23]Tournamille C, Colin Y, Cartron JP, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffynegative individuals. Nat Genet 1995;10:224–8.10.1038/ng0695-224Search in Google Scholar

[24]Olsson ML, Hansson C, Avent ND, Akesson IE, Green CA, Daniels GL.A clinically applicable method for determining the three major alleles at the Duffy (FY) blood group locus using polymerase chain reaction with allele-specific primers. Transfusion 1998;38: 168–73.10.1046/j.1537-2995.1998.38298193099.xSearch in Google Scholar

[25]Tournamille C, Le Van Kim C, Gane P, et al.Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals. Blood 1998;92:2147–56.10.1182/blood.V92.6.2147Search in Google Scholar

[26]Olsson ML, Smythe JS, Hansson C, et al. The Fy(x) phenotype is associated with a missense mutation in the Fy(b) allele predicting Arg89Cys in the Duffy glycoprotein. Br J Haematol 1998;103:1184–91.10.1046/j.1365-2141.1998.01083.xSearch in Google Scholar

[27]Parasol N, Reid M, Rios M, Castilho L, Harari I, Kosower NS. A novel mutation in the coding sequence of the FY*B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phenotype. Blood 1998;92:2237–43.10.1182/blood.V92.7.2237Search in Google Scholar

[28]Newton CR, Graham A, Heptinstall LE, et.al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989;17:2503-16.10.1093/nar/17.7.2503Search in Google Scholar

[29]Gassner C, Schmarda A, Kilga-Nogler S, et al. RHD/CE typing by polymerase chain reaction using sequence-specific primers. Transfusion 1997;37: 1020–6.10.1046/j.1537-2995.1997.371098016439.xSearch in Google Scholar

[30]Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.10.1093/nar/16.3.1215Search in Google Scholar

[31]Chen EY, Liao YC, Smith DH, Barrera-Saldana HA, Gelinas RE, Seeburg PH. The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics 1989;4:479–97.10.1016/0888-7543(89)90271-1Search in Google Scholar

[32]Moulds JM, Hayes S, Wells TD. DNA analysis of Duffy genes in American blacks.Vox Sang 1998;74:248-5.10.1046/j.1423-0410.1998.7440248.xSearch in Google Scholar

[33]Wagner FF, Gassner C, Muller TH, Schonitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood 1999;93:385–93.10.1182/blood.V93.1.385Search in Google Scholar